Status:
COMPLETED
Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan
Lead Sponsor:
Maria de los Angeles Peral de Bruno
Conditions:
Covid19
SARS (Severe Acute Respiratory Syndrome)
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
PHASE2
Brief Summary
IMPORTANCE: The emergency of COVID-19 requires the implementation of urgent strategies to prevent the spread of the disease, mainly in health personnel, who are the most exposed and has the highest ri...
Detailed Description
The subjects were divided into experimental (EG: n=117; 39.6 +/- 9.4 years old, 65F) and control groups (CG: n=117; 38.4 +/- 7.4 years old, 61F). RESULT: The number of subjects who were diagnosed wit...
Eligibility Criteria
Inclusion
- Personnel who perform patient care and administrative tasks:
- medical personnel,
- nurses,
- kinesiologists,
- orderlies,
- administrative,
- cleaning personnel.
Exclusion
- People under 18 years of age,
- Pregnant or actively breastfeeding women,
- Presenting symptoms related to COVID-19 disease,
- Concurrent autoimmune or chronic disease,
- Immunosuppression,
- Active infectious diseases,
- History of previous SARSCoV-2 infection confirmed by RT-PCR or rapid test.
Key Trial Info
Start Date :
October 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04701710
Start Date
October 15 2020
End Date
December 31 2020
Last Update
February 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SI.PRO.SA, Ministerio de Salud Pública
San Miguel de Tucumán, Argentina, 4000